Internal Medicine, Hematology · San Francisco, CA
NPI
1952343113
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
505 Parnassus Ave
San Francisco, CA, 94143
Phone (415) 514-3432
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.4M
2,120,399 services
Medicare patients, 2024
357
Average age 71
Drug cost, 2024
$820K
334 prescriptions
Company payments, 2025
$33K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew D Leavitt was code 99215 (office e&m - established), 202 times for 125 patients. In total Andrew D Leavitt billed 2,120,399 services in 30 codes, and Medicare paid $4.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 202 | 125 | $119.41 | $24K |
| 99451 E&M - Miscellaneous | Facility | 133 | 120 | $30.78 | $4,094 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 69 | 45 | $26.59 | $1,835 |
| 99232 Hospital E&M - Subsequent | Facility | 37 | 24 | $70.11 | $2,594 |
| 99205 Office E&M - New | Facility | 33 | 33 | $151.10 | $4,986 |
| 99222 Hospital E&M - Initial | Facility | 33 | 33 | $115.45 | $3,810 |
| 99214 Office E&M - Established | Facility | 29 | 25 | $67.29 | $1,952 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 18 | $105.14 | $2,313 |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $153.48 | $3,223 |
By year: 2022 $3.8M for 2,419,294 services; 2023 $4.8M for 2,541,972 services; 2024 $4.4M for 2,120,399 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew D Leavitt prescribed most often to Medicare patients was Eliquis (Apixaban), with 122 prescriptions and refills. In total Andrew D Leavitt wrote 334 Medicare prescriptions that cost $820K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 122 | 258 | 32 | $149K |
| Xarelto Rivaroxaban | 48 | 105 | 14 | $54K |
| Promacta Eltrombopag Olamine | 42 | 44 | Under 11 | $598K |
| Tranexamic Acid Generic | 37 | 50 | Under 11 | $15K |
| Hydroxyurea Generic | 30 | 70 | Under 11 | $771 |
| Cyclosporine Modified Cyclosporine, Modified | 12 | 22 | Under 11 | $2,511 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 23 | Under 11 | $54.44 |
Brand drugs: 246 claims; generic drugs: 88 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew D Leavitt $33K ($29K in general payments such as food, travel and fees and $4,140 for research) from 4 companies. The largest payer was BioMarin Pharmaceutical Inc. with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.